 | • レポートコード：MRC23Q35877 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の臨床試験イメージングシステム市場について調査・分析し、世界の臨床試験イメージングシステム市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（プロジェクト＆データ管理、臨床試験デザイン＆コンサルテーション、読解＆分析、オペレーショナルイメージング、その他）、用途別セグメント分析（バイオテクノロジー＆製薬会社、医療機器製造業者、受託研究機関、学術＆政府研究機関、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Bioclinica、Ixico、Icon、Intrinsic Imaging、Radiant Sage、Parexel International Corporation、Biomedical Systems Worldcare Clinical、Medpace、Navitas Life Sciences、Prism Clinical Imaging、Resonance Health、VirtualScopic、BioTelemetricなどが含まれています。世界の臨床試験イメージングシステム市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、臨床試験イメージングシステム市場規模を推定する際に考慮しました。本レポートは、臨床試験イメージングシステムの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、臨床試験イメージングシステムに関するビジネス上の意思決定に役立てることを目的としています。 ・臨床試験イメージングシステム市場の概要 - 臨床試験イメージングシステムのタイプ別セグメント - 世界の臨床試験イメージングシステム市場規模：タイプ別分析（プロジェクト＆データ管理、臨床試験デザイン＆コンサルテーション、読解＆分析、オペレーショナルイメージング、その他） - 臨床試験イメージングシステムの用途別セグメント - 世界の臨床試験イメージングシステム市場規模：用途別分析（バイオテクノロジー＆製薬会社、医療機器製造業者、受託研究機関、学術＆政府研究機関、その他） - 世界の臨床試験イメージングシステム市場規模予測（2018年-2029年） ・臨床試験イメージングシステム市場の成長トレンド - 臨床試験イメージングシステムの地域別市場規模（2018年-2029年） - 臨床試験イメージングシステム市場ダイナミクス - 臨床試験イメージングシステムの業界動向 - 臨床試験イメージングシステム市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：プロジェクト＆データ管理、臨床試験デザイン＆コンサルテーション、読解＆分析、オペレーショナルイメージング、その他 - 世界の臨床試験イメージングシステムのタイプ別市場規模（2018年-2023年） - 世界の臨床試験イメージングシステムのタイプ別市場規模（2024年-2029年） ・用途別セグメント：バイオテクノロジー＆製薬会社、医療機器製造業者、受託研究機関、学術＆政府研究機関、その他 - 世界の臨床試験イメージングシステムの用途別市場規模（2018年-2023年） - 世界の臨床試験イメージングシステムの用途別市場規模（2024年-2029年） ・臨床試験イメージングシステムの地域別市場規模 - 北米の臨床試験イメージングシステム市場規模（2018年-2029年） - アメリカの臨床試験イメージングシステム市場規模（2018年-2029年） - ヨーロッパの臨床試験イメージングシステム市場規模（2018年-2029年） - アジア太平洋の臨床試験イメージングシステム市場規模（2018年-2029年） - 中国の臨床試験イメージングシステム市場規模（2018年-2029年） - 日本の臨床試験イメージングシステム市場規模（2018年-2029年） - 韓国の臨床試験イメージングシステム市場規模（2018年-2029年） - インドの臨床試験イメージングシステム市場規模（2018年-2029年） - オーストラリアの臨床試験イメージングシステム市場規模（2018年-2029年） - 中南米の臨床試験イメージングシステム市場規模（2018年-2029年） - 中東・アフリカの臨床試験イメージングシステム市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Bioclinica、Ixico、Icon、Intrinsic Imaging、Radiant Sage、Parexel International Corporation、Biomedical Systems Worldcare Clinical、Medpace、Navitas Life Sciences、Prism Clinical Imaging、Resonance Health、VirtualScopic、BioTelemetric ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Clinical Trial Imaging System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Clinical Trial Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Clinical Trial Imaging System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Clinical Trial Imaging System in Biotechnology and Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Clinical Trial Imaging System include Bioclinica, Ixico, Icon, Intrinsic Imaging, Radiant Sage, Parexel International Corporation, Biomedical Systems Worldcare Clinical, Medpace and Navitas Life Sciences, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Clinical Trial Imaging System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Imaging System.
The Clinical Trial Imaging System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Clinical Trial Imaging System market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Trial Imaging System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bioclinica
Ixico
Icon
Intrinsic Imaging
Radiant Sage
Parexel International Corporation
Biomedical Systems Worldcare Clinical
Medpace
Navitas Life Sciences
Prism Clinical Imaging
Resonance Health
VirtualScopic
BioTelemetric
Segment by Type
Project and Data Management
Clinical Trial Design and Consultation
Reading and Analytical
Operational Imaging
Others
Segment by Application
Biotechnology and Pharmaceutical Companies
Medical Devices Manufacturers
Contract Research Organizations
Academic and Government Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Trial Imaging System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Trial Imaging System Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Project and Data Management
1.2.3 Clinical Trial Design and Consultation
1.2.4 Reading and Analytical
1.2.5 Operational Imaging
1.2.6 Others
1.3 Market by Application
1.3.1 Global Clinical Trial Imaging System Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Medical Devices Manufacturers
1.3.4 Contract Research Organizations
1.3.5 Academic and Government Research Institutes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Trial Imaging System Market Perspective (2018-2029)
2.2 Clinical Trial Imaging System Growth Trends by Region
2.2.1 Global Clinical Trial Imaging System Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Clinical Trial Imaging System Historic Market Size by Region (2018-2023)
2.2.3 Clinical Trial Imaging System Forecasted Market Size by Region (2024-2029)
2.3 Clinical Trial Imaging System Market Dynamics
2.3.1 Clinical Trial Imaging System Industry Trends
2.3.2 Clinical Trial Imaging System Market Drivers
2.3.3 Clinical Trial Imaging System Market Challenges
2.3.4 Clinical Trial Imaging System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Trial Imaging System Players by Revenue
3.1.1 Global Top Clinical Trial Imaging System Players by Revenue (2018-2023)
3.1.2 Global Clinical Trial Imaging System Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Trial Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Clinical Trial Imaging System Revenue
3.4 Global Clinical Trial Imaging System Market Concentration Ratio
3.4.1 Global Clinical Trial Imaging System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Trial Imaging System Revenue in 2022
3.5 Clinical Trial Imaging System Key Players Head office and Area Served
3.6 Key Players Clinical Trial Imaging System Product Solution and Service
3.7 Date of Enter into Clinical Trial Imaging System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Trial Imaging System Breakdown Data by Type
4.1 Global Clinical Trial Imaging System Historic Market Size by Type (2018-2023)
4.2 Global Clinical Trial Imaging System Forecasted Market Size by Type (2024-2029)
5 Clinical Trial Imaging System Breakdown Data by Application
5.1 Global Clinical Trial Imaging System Historic Market Size by Application (2018-2023)
5.2 Global Clinical Trial Imaging System Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Clinical Trial Imaging System Market Size (2018-2029)
6.2 North America Clinical Trial Imaging System Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Clinical Trial Imaging System Market Size by Country (2018-2023)
6.4 North America Clinical Trial Imaging System Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Trial Imaging System Market Size (2018-2029)
7.2 Europe Clinical Trial Imaging System Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Clinical Trial Imaging System Market Size by Country (2018-2023)
7.4 Europe Clinical Trial Imaging System Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Trial Imaging System Market Size (2018-2029)
8.2 Asia-Pacific Clinical Trial Imaging System Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Clinical Trial Imaging System Market Size by Region (2018-2023)
8.4 Asia-Pacific Clinical Trial Imaging System Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Trial Imaging System Market Size (2018-2029)
9.2 Latin America Clinical Trial Imaging System Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Clinical Trial Imaging System Market Size by Country (2018-2023)
9.4 Latin America Clinical Trial Imaging System Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Trial Imaging System Market Size (2018-2029)
10.2 Middle East & Africa Clinical Trial Imaging System Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Clinical Trial Imaging System Market Size by Country (2018-2023)
10.4 Middle East & Africa Clinical Trial Imaging System Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bioclinica
11.1.1 Bioclinica Company Detail
11.1.2 Bioclinica Business Overview
11.1.3 Bioclinica Clinical Trial Imaging System Introduction
11.1.4 Bioclinica Revenue in Clinical Trial Imaging System Business (2018-2023)
11.1.5 Bioclinica Recent Development
11.2 Ixico
11.2.1 Ixico Company Detail
11.2.2 Ixico Business Overview
11.2.3 Ixico Clinical Trial Imaging System Introduction
11.2.4 Ixico Revenue in Clinical Trial Imaging System Business (2018-2023)
11.2.5 Ixico Recent Development
11.3 Icon
11.3.1 Icon Company Detail
11.3.2 Icon Business Overview
11.3.3 Icon Clinical Trial Imaging System Introduction
11.3.4 Icon Revenue in Clinical Trial Imaging System Business (2018-2023)
11.3.5 Icon Recent Development
11.4 Intrinsic Imaging
11.4.1 Intrinsic Imaging Company Detail
11.4.2 Intrinsic Imaging Business Overview
11.4.3 Intrinsic Imaging Clinical Trial Imaging System Introduction
11.4.4 Intrinsic Imaging Revenue in Clinical Trial Imaging System Business (2018-2023)
11.4.5 Intrinsic Imaging Recent Development
11.5 Radiant Sage
11.5.1 Radiant Sage Company Detail
11.5.2 Radiant Sage Business Overview
11.5.3 Radiant Sage Clinical Trial Imaging System Introduction
11.5.4 Radiant Sage Revenue in Clinical Trial Imaging System Business (2018-2023)
11.5.5 Radiant Sage Recent Development
11.6 Parexel International Corporation
11.6.1 Parexel International Corporation Company Detail
11.6.2 Parexel International Corporation Business Overview
11.6.3 Parexel International Corporation Clinical Trial Imaging System Introduction
11.6.4 Parexel International Corporation Revenue in Clinical Trial Imaging System Business (2018-2023)
11.6.5 Parexel International Corporation Recent Development
11.7 Biomedical Systems Worldcare Clinical
11.7.1 Biomedical Systems Worldcare Clinical Company Detail
11.7.2 Biomedical Systems Worldcare Clinical Business Overview
11.7.3 Biomedical Systems Worldcare Clinical Clinical Trial Imaging System Introduction
11.7.4 Biomedical Systems Worldcare Clinical Revenue in Clinical Trial Imaging System Business (2018-2023)
11.7.5 Biomedical Systems Worldcare Clinical Recent Development
11.8 Medpace
11.8.1 Medpace Company Detail
11.8.2 Medpace Business Overview
11.8.3 Medpace Clinical Trial Imaging System Introduction
11.8.4 Medpace Revenue in Clinical Trial Imaging System Business (2018-2023)
11.8.5 Medpace Recent Development
11.9 Navitas Life Sciences
11.9.1 Navitas Life Sciences Company Detail
11.9.2 Navitas Life Sciences Business Overview
11.9.3 Navitas Life Sciences Clinical Trial Imaging System Introduction
11.9.4 Navitas Life Sciences Revenue in Clinical Trial Imaging System Business (2018-2023)
11.9.5 Navitas Life Sciences Recent Development
11.10 Prism Clinical Imaging
11.10.1 Prism Clinical Imaging Company Detail
11.10.2 Prism Clinical Imaging Business Overview
11.10.3 Prism Clinical Imaging Clinical Trial Imaging System Introduction
11.10.4 Prism Clinical Imaging Revenue in Clinical Trial Imaging System Business (2018-2023)
11.10.5 Prism Clinical Imaging Recent Development
11.11 Resonance Health
11.11.1 Resonance Health Company Detail
11.11.2 Resonance Health Business Overview
11.11.3 Resonance Health Clinical Trial Imaging System Introduction
11.11.4 Resonance Health Revenue in Clinical Trial Imaging System Business (2018-2023)
11.11.5 Resonance Health Recent Development
11.12 VirtualScopic
11.12.1 VirtualScopic Company Detail
11.12.2 VirtualScopic Business Overview
11.12.3 VirtualScopic Clinical Trial Imaging System Introduction
11.12.4 VirtualScopic Revenue in Clinical Trial Imaging System Business (2018-2023)
11.12.5 VirtualScopic Recent Development
11.13 BioTelemetric
11.13.1 BioTelemetric Company Detail
11.13.2 BioTelemetric Business Overview
11.13.3 BioTelemetric Clinical Trial Imaging System Introduction
11.13.4 BioTelemetric Revenue in Clinical Trial Imaging System Business (2018-2023)
11.13.5 BioTelemetric Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details